Washington, DC, May 01, 2023 (GLOBE NEWSWIRE) — On Friday, the Institute for Clinical and Economic Review (ICER) held a public hearing to review its draft assessment of Resmetirom and Obeticholic Acid (OCA) for Non-Alcoholic Steatohepatitis: Effectiveness and Value. While the evidence presented for both drugs was deemed effective in…Read More
ICER MIDWEST CEPAC WORKS TO KEEP UP WITH WELLINFORMED NASH PATIENT ADVOCATES
